Molina Healthcare (NYSE:MOH) Lowered to Underperform at Bank of America

Bank of America lowered shares of Molina Healthcare (NYSE:MOH) from a neutral rating to an underperform rating in a report issued on Thursday, Marketbeat.com reports. The brokerage currently has $439.00 price target on the stock.

Several other equities research analysts also recently commented on MOH. Truist Financial boosted their target price on Molina Healthcare from $435.00 to $460.00 and gave the stock a buy rating in a report on Tuesday, February 20th. StockNews.com downgraded Molina Healthcare from a strong-buy rating to a buy rating in a report on Thursday, February 8th. Wells Fargo & Company upped their price target on Molina Healthcare from $420.00 to $440.00 and gave the company an equal weight rating in a report on Wednesday, March 20th. UBS Group upped their price target on Molina Healthcare from $350.00 to $380.00 and gave the company a neutral rating in a report on Thursday, December 21st. Finally, Cantor Fitzgerald upped their price target on Molina Healthcare from $374.00 to $406.00 and gave the company an overweight rating in a report on Friday, February 9th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and five have given a buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of Hold and a consensus target price of $395.82.

Molina Healthcare Trading Down 1.9 %

Molina Healthcare stock opened at $410.85 on Thursday. The company has a current ratio of 1.54, a quick ratio of 1.54 and a debt-to-equity ratio of 0.57. The business’s fifty day simple moving average is $389.58 and its two-hundred day simple moving average is $365.82. Molina Healthcare has a 12 month low of $263.20 and a 12 month high of $423.92. The company has a market capitalization of $24.07 billion, a price-to-earnings ratio of 21.88, a price-to-earnings-growth ratio of 1.17 and a beta of 0.47.

Molina Healthcare (NYSE:MOH) last released its earnings results on Wednesday, February 7th. The company reported $4.38 EPS for the quarter, topping the consensus estimate of $4.31 by $0.07. Molina Healthcare had a return on equity of 32.34% and a net margin of 3.20%. The business had revenue of $9.05 billion for the quarter, compared to the consensus estimate of $8.35 billion. During the same period in the previous year, the company posted $4.10 earnings per share. The company’s revenue for the quarter was up 10.0% compared to the same quarter last year. As a group, equities analysts predict that Molina Healthcare will post 23.62 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Molina Healthcare news, CFO Mark Lowell Keim sold 15,000 shares of the company’s stock in a transaction dated Monday, February 12th. The stock was sold at an average price of $386.56, for a total value of $5,798,400.00. Following the completion of the sale, the chief financial officer now owns 36,531 shares in the company, valued at $14,121,423.36. The sale was disclosed in a document filed with the SEC, which is accessible through this link. In other Molina Healthcare news, CFO Mark Lowell Keim sold 15,000 shares of the company’s stock in a transaction dated Monday, February 12th. The stock was sold at an average price of $386.56, for a total value of $5,798,400.00. Following the completion of the sale, the chief financial officer now owns 36,531 shares in the company, valued at $14,121,423.36. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Richard M. Schapiro sold 1,000 shares of the company’s stock in a transaction dated Tuesday, February 20th. The stock was sold at an average price of $401.05, for a total value of $401,050.00. Following the completion of the sale, the director now owns 11,207 shares of the company’s stock, valued at approximately $4,494,567.35. The disclosure for this sale can be found here. Insiders sold a total of 16,711 shares of company stock worth $6,472,517 over the last quarter. 1.10% of the stock is currently owned by corporate insiders.

Institutional Trading of Molina Healthcare

Several institutional investors have recently made changes to their positions in MOH. Annis Gardner Whiting Capital Advisors LLC purchased a new stake in shares of Molina Healthcare during the third quarter worth about $30,000. ST Germain D J Co. Inc. purchased a new stake in shares of Molina Healthcare during the second quarter worth about $33,000. McIlrath & Eck LLC purchased a new stake in shares of Molina Healthcare during the fourth quarter worth about $34,000. Coppell Advisory Solutions Corp. purchased a new stake in shares of Molina Healthcare during the fourth quarter worth about $34,000. Finally, VisionPoint Advisory Group LLC grew its position in shares of Molina Healthcare by 105.6% during the third quarter. VisionPoint Advisory Group LLC now owns 111 shares of the company’s stock worth $36,000 after purchasing an additional 57 shares in the last quarter. Hedge funds and other institutional investors own 98.50% of the company’s stock.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.